OMCLOmnicell, Inc.

$35.81+14% 1Y

Is it growing?

Good

Growing: earnings up +68% year on year and operating margin widening (+3.4 points).

2 good, 1 neutral
Revenue trend+8% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +5% a year.

Earnings trend+68% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+3.4 points operating

Trailing-twelve-month operating margin, 4.7% now against 1.2% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 77% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is OMCL growing?

Omnicell, Inc. has grown revenue 0.31% a year over three years and 4.8% a year over five, with earnings per share compounding at −31%.

+0.31%

Revenue growth, 3-year annual rate · Health Information Services median +10% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+4.8%

Revenue growth, 5-year rate · +0.31% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
−31%

Earnings per share, 3-year rate · revenue +0.31% · earnings lagged revenue: the growth is costing something

Years of annual history on file
17

Years of annual history on file · FY2009 to FY2025, as filed

Details›
Revenue FY2021
$1.13B
Revenue FY2022
$1.30B
Revenue FY2023
$1.15B
Revenue FY2024
$1.11B
Revenue FY2025
$1.18B

Annual income statements as filed with the SEC.